Reports and Briefs on Pharmaceuticals and Healthcare

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

Forecast: Rheumatoid Arthritis in the US, Japan, and 5EU

Datamonitor Healthcare uses a patient-based approach to size the rheumatoid arthritis (RA) market in the US, Japan, and five major EU markets from 2014 to 2023, focusing on traditional and biologic disease-modifying therapies.

Published By Datamonitor
24 Apr 2015 $2800
Buy
Report
Report

Treatment: Rheumatoid Arthritis

Through our in-house primary research, Datamonitor Healthcare has produced thorough analysis on rheumatoid arthritis (RA) treatment trends, outcomes, and unmet needs.

Published By Datamonitor
23 Apr 2015 $2800
Buy
Report
Report

Marketed Drugs: Rheumatoid Arthritis

Our marketed drugs analysis gives an overview of market behaviors as well as individual commercial and clinical attractiveness.

Published By Datamonitor
23 Apr 2015 $2800
Buy
Report
Report

Pipeline: Rheumatoid Arthritis

Our pipeline product analysis gives an overview of how pipeline products in general are expected to perform, as well as early-phase projections and individual pipeline forecasts.

Published By Datamonitor
21 Apr 2015 $2800
Buy
Report
Report

Access in Emerging Markets: HTA is Making Inroads

In this report, we look at the evolution of health technology assessment (HTA) in emerging market countries.

Published By Datamonitor
16 Apr 2015 $2000
Buy
Brief
Brief

The Evolving Landscape in Biosimilars

Biosimilars offer significant opportunities, but only players with well-positioned offerings will see success in this challenging segment.

Published By Datamonitor
17 Mar 2015 $1200
Buy
Report
Report

China Hospital Directory

Listing of 21,729 hospitals in China, providing the following fields: name, province, state, telephone number, hospital grade, hospital tier, bed count, physician count, revenue from medical services, and revenue from pharmaceutical sales.

Published By Datamonitor
11 Dec 2013 $1520
Buy
Report
Report

Rheumatoid Arthritis - Pipeline

Review of candidates in development for rheumatoid arthritis across the US, Japan, and five major EU markets.

Published By Datamonitor
03 Dec 2013 $2000
Buy
Report
Report

Rheumatoid Arthritis - Marketed Drugs

In-depth analysis of marketed drugs for rheumatoid arthritis, including lifecycle management strategies, new clinical data and an evaluation of clinical and commercial drug attributes to understand competitiveness in the marketplace.

Published By Datamonitor
03 Dec 2013 $2000
Buy
Report
Report

Rheumatoid Arthritis - Forecast

Becoming increasingly difficult for developers of novel products to penetrate the rheumatoid arthritis market

Published By Datamonitor
03 Dec 2013 $2000
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.